These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19104228)

  • 1. The design and interpretation of pilot trials in clinical research in critical care.
    Arnold DM; Burns KE; Adhikari NK; Kho ME; Meade MO; Cook DJ;
    Crit Care Med; 2009 Jan; 37(1 Suppl):S69-74. PubMed ID: 19104228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acupuncture for chronic neck pain: a pilot for a randomised controlled trial.
    Salter GC; Roman M; Bland MJ; MacPherson H
    BMC Musculoskelet Disord; 2006 Dec; 7():99. PubMed ID: 17156464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial design issues: at least 10 things you should look for in clinical trials.
    Glasser SP; Howard G
    J Clin Pharmacol; 2006 Oct; 46(10):1106-15. PubMed ID: 16988199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and analysis of group-randomized trials in cancer: a review of current practices.
    Murray DM; Pals SL; Blitstein JL; Alfano CM; Lehman J
    J Natl Cancer Inst; 2008 Apr; 100(7):483-91. PubMed ID: 18364501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of underpowered randomized clinical trials in rheumatology.
    Keen HI; Pile K; Hill CL
    J Rheumatol; 2005 Nov; 32(11):2083-8. PubMed ID: 16265683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Better conduct of clinical trials: the control group in critical care trials.
    Takala J
    Crit Care Med; 2009 Jan; 37(1 Suppl):S80-90. PubMed ID: 19104230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key issues in end point selection for heart failure trials: composite end points.
    Neaton JD; Gray G; Zuckerman BD; Konstam MA
    J Card Fail; 2005 Oct; 11(8):567-75. PubMed ID: 16230258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in the quality of randomized controlled trials among general anesthesiology journals 2000 to 2006: a 6-year follow-up.
    Greenfield ML; Mhyre JM; Mashour GA; Blum JM; Yen EC; Rosenberg AL
    Anesth Analg; 2009 Jun; 108(6):1916-21. PubMed ID: 19448222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of piloting an RCT intervention.
    Feeley N; Cossette S; Côté J; Héon M; Stremler R; Martorella G; Purden M
    Can J Nurs Res; 2009 Jun; 41(2):85-99. PubMed ID: 19650515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the validity and utility of randomized clinical trials in addictions treatment research: II. Participant samples and assessment.
    Del Boca FK; Darkes J
    Addiction; 2007 Aug; 102(8):1194-203. PubMed ID: 17511752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations in determining sample size for pilot studies.
    Hertzog MA
    Res Nurs Health; 2008 Apr; 31(2):180-91. PubMed ID: 18183564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems in the conduct and analysis of randomized clinical trials. Are we getting the right answers to the wrong questions?
    Rabeneck L; Viscoli CM; Horwitz RI
    Arch Intern Med; 1992 Mar; 152(3):507-12. PubMed ID: 1546913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward rapproachment in the placebo control debate. A calculated compromise of power.
    Leon AC; Solomon DA
    Eval Health Prof; 2003 Dec; 26(4):404-14. PubMed ID: 14631611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific barriers to the conduct of randomized trials.
    Duley L; Antman K; Arena J; Avezum A; Blumenthal M; Bosch J; Chrolavicius S; Li T; Ounpuu S; Perez AC; Sleight P; Svard R; Temple R; Tsouderous Y; Yunis C; Yusuf S
    Clin Trials; 2008; 5(1):40-8. PubMed ID: 18283079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimising the design of phase II oncology trials: the importance of randomisation.
    Ratain MJ; Sargent DJ
    Eur J Cancer; 2009 Jan; 45(2):275-80. PubMed ID: 19059773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic randomized clinical trial is the best solution for management issues in critical limb ischemia.
    de Graaff JC; Ubbink DT; Tijssen JG; Legemate DA
    J Clin Epidemiol; 2004 Nov; 57(11):1111-8. PubMed ID: 15567626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues in the planning and conduct of randomised trials.
    Bhandari M; Pape HC; Giannoudis PV
    Injury; 2006 Apr; 37(4):349-54. PubMed ID: 16487524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for determining the size of internal pilot studies.
    Sandvik L; Erikssen J; Mowinckel P; Rødland EA
    Stat Med; 1996 Jul; 15(14):1587-90. PubMed ID: 8855484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial design in systemic lupus erythematosus.
    Dall'Era M; Wofsy D
    Curr Opin Rheumatol; 2006 Sep; 18(5):476-80. PubMed ID: 16896285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.